KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)

128 filings reported holding KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q4 2023.
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 36,983,052 shares of 50,000,000 outstanding shares and own 73.97% of the company stock.
Largest 10 shareholders include VR Adviser, LLC (4,092,731 shares), Frazier Life Sciences Management, L.P. (3,622,294 shares), TANG CAPITAL MANAGEMENT LLC (3,440,345 shares), TCG Crossover Management, LLC (3,395,495 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2,684,005 shares), BlackRock Inc. (2,242,025 shares), Saturn V Capital Management LP (1,807,563 shares), VANGUARD GROUP INC (1,781,419 shares), Boxer Capital, LLC (1,650,000 shares), and Jefferies Financial Group Inc. (1,080,000 shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.